Noara Therapeutics
1 known investors
Find your way into Noara Therapeutics
Sign up to see every warm intro you have to Noara Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Noara Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Noara Therapeutics develops a new class of therapeutic RNA using its MITREN platform, which combines machine intelligence with RNA engineering to design RNA molecules that are immunosilent, active, and stable. The company targets limitations of existing RNA modalities for broader therapeutic use beyond vaccines, including applications in metabolic disease.
Investors · 1
Frequently asked questions
- What does Noara Therapeutics do?
- Noara Therapeutics develops a new class of therapeutic RNA using its MITREN platform, which combines machine intelligence with RNA engineering to design RNA molecules that are immunosilent, active, and stable. The company targets limitations of existing RNA modalities for broader therapeutic use beyond vaccines, including applications in metabolic disease.
- Who are Noara Therapeutics's investors?
- Noara Therapeutics's investors include AIR Capital.
